Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MP-0310 by Molecular Partners for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
MP-0310 is under clinical development by Molecular Partners and currently in Phase I for Cutaneous Squamous Cell Carcinoma (cSCC). According...
Data Insights
MP-0310 by Molecular Partners for Breast Cancer: Likelihood of Approval
MP-0310 is under clinical development by Molecular Partners and currently in Phase I for Breast Cancer. According to GlobalData, Phase...